Advancing the Development of Therapeutics Against Infectious Diseases

Novel and emerging infectious diseases can be a serious threat to human health and the global economy, as exhibited by the current SARS-CoV-2 outbreak. To mitigate these threats, it is necessary to initiate comprehensive containment strategies such as virus characterization, serological testing, therapeutic  antibody research and vaccine development using optimized protein expression systems to combat rapidly evolving pathogens.

Download this whitepaper to discover a solution that:

• Provides superior protein yields and reproducibility
• Maintains simplicity, speed and ease of use
• Offers integrated solutions to fuel infectious disease research